Nutrition, Microbiome and Bone Health During Early Life Related to Health
NCT ID: NCT05160675
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2760 participants
OBSERVATIONAL
2021-09-03
2025-09-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Linking Dietary Nutrition, Dietary Patterns, Gut Microbiota, and Bone Density: A Cross-Sectional Study
NCT07256314
Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture
NCT04265742
Skeletal Maturation and Endocrine Health in Young Adults
NCT06509776
Role of Cardiometabolic Risk Factors in Childhood Bone Development
NCT02355717
Influence of External Factors on Skeletal Growth in Youth
NCT00633828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Establish the reference trajectories of gut microbiome maturation index and bone development in healthy Chinese children aged 0-3years
* Assess the impact of early life nutrition on gut microbiome trajectory
* Investigate the influence of microbiome, early life parameters and nutritional parameters on bone health
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1: 690 healthy infants and their mother followed from birth to 12 months
No intervention
Group 2
Group 2: 690 healthy infants and their mother followed from 6 months to 3 years of age
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject's parent(s)/LAR is of legal age of consent, is willing and able to fulfill the requirements of the study protocol.
3. For group 1, healthy infants aged ≤ 10 days after birth (date of birth = Day 0).
For group 2, healthy infants with maximum age of 6 months
4. Full-term gestational birth (≥ 37 and ≤ 42 weeks).
5. Subject's parent(s)/LAR is able to be contacted directly by telephone throughout the study.
6. Both parents registered have a fixed work and / or residence within their jurisdiction.
Exclusion Criteria
2. Infant's parents/LAR not willing and/or not able to comply with scheduled visits and the requirements of the study protocol
3. Currently participating or having participated in another clinical trial within 4 weeks prior to trial start.
0 Days
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin Women and Children's Health Center
OTHER
BGI-research
OTHER
Cognizant Technology Solutions AG
UNKNOWN
SAS Institute
INDUSTRY
Veeva Systems
INDUSTRY
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gongshu Liu, Dr.
Role: PRINCIPAL_INVESTIGATOR
Tianjin Women and Children Health Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tianjin Women and Children Health Center,
Tianjin, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20.27.NRC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.